RESUMO
In order for special hospitals to survive and develop in the fierce market competitions, it is imperative for them to enhance their competitiveness, the key to which lies in accelerating personnel training. For this reason, it is necessary to take the following steps: changing concepts, identifying goals, implementing personnel training strategies and taking the initiative in selecting talented personnel; making exertions in personnel training through expanding channels and conducting classifications; creating the right circumstances, optimizing the environment and making a rational use of personnel; adopting innovative mechanisms, perfecting systems and scientifically managing personnel. It is important to take specialty advancement as the guide, personnel training as the prop, and scientific research and teaching as the driving force in achieving the sustainable development of special hospitals.
RESUMO
Objective To study the clinical therapeutic effectiveness and the mechanism of Shouti Oral Liquid on simple obesity children with hyperinsulinism. Methods Fourty - three patients were divided randomly into the treatment group (TG) and the control group (CG). TG took Shouti Oral Liquid and CG took metformin. The course of therapy lasted 6 months. The plasma lipid, body fats, insulin resistance index (IR) and some hormones related to obesity before and after therapy were measured and the changes were analyzed. Results The weight, F% , body mass index (BMI), leptin(LP), tumor necrosing factor (TNF - ?), FINS, IR all declined markedly than pre - therapy in both groups. The significant effect, normal effect and total efficiency were 22.7 % , 59.1 %, 81.8 % respectively in TG and9.5%,52.4%,61.9% in CG. The effect in TG was better than that in CG. A short course with Shouti Oral Liquid therapy did not have obvious side effect Conclusions There are lipid metabolism disorder, insulin resistance and high lever LP and TNF - ? obesity children with hyperinsulinism. The total effect with Shouti Oral Liquid is better than that with medicine in the control group and the mechanism was regulating lipid metabolism, decreasing LP and TNF-? and ameliorating insulin resistance.